These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17622802)

  • 1. HPV vaccine facts: can't see the forest through the trees.
    Bryan J
    Hum Vaccin; 2007; 3(6):295-6. PubMed ID: 17622802
    [No Abstract]   [Full Text] [Related]  

  • 2. No Vacillation on HPV Vaccination.
    Sipp D; Frazer IH; Rasko JEJ
    Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.
    Kaur P; Mehrotra R; Rengaswamy S; Kaur T; Hariprasad R; Mehendale SM; Rajaraman P; Rath GK; Bhatla N; Krishnan S; Nayyar A; Swaminathan S
    Indian J Med Res; 2017 Aug; 146(2):153-157. PubMed ID: 29265015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of cervical cancer by HPV vaccine].
    Konno R
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):236-9. PubMed ID: 20235395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
    Villa LL
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.
    Hum Vaccin Immunother; 2014; 10(11):3105-6. PubMed ID: 25789368
    [No Abstract]   [Full Text] [Related]  

  • 8. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards global prevention of human papillomavirus-induced cancer.
    Roden RB; Gravitt P; Wu TC
    Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV vaccination in Italy: perspectives after 1-year experience.
    Icardi G
    J Prev Med Hyg; 2008 Dec; 49(4):125-8. PubMed ID: 19350958
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed HPV vaccine mandates rile health experts across the country.
    Savage L
    J Natl Cancer Inst; 2007 May; 99(9):665-6. PubMed ID: 17470731
    [No Abstract]   [Full Text] [Related]  

  • 13. The new HPV vaccine--be sure you know the facts.
    Zarbock S
    JAAPA; 2006 Sep; 19(9):14-5. PubMed ID: 16999282
    [No Abstract]   [Full Text] [Related]  

  • 14. HPV vaccine protects at multiple sites, even for some previously exposed.
    Printz C
    Cancer; 2015 Sep; 121(17):2863. PubMed ID: 26291437
    [No Abstract]   [Full Text] [Related]  

  • 15. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R; Andrei C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines. Can vaccines against HPV work in PHAs?
    TreatmentUpdate; 2005; 17(1):12-4. PubMed ID: 17228461
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV-related cancer prevention through coalition building.
    Lind E; Welch K; Perkins RB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2300-2306. PubMed ID: 28901813
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women.
    Bhatla N; Suri V; Basu P; Shastri S; Datta SK; Bi D; Descamps DJ; Bock HL;
    J Obstet Gynaecol Res; 2010 Feb; 36(1):123-32. PubMed ID: 20178538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ
    Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849
    [No Abstract]   [Full Text] [Related]  

  • 20. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil): profile report.
    Siddiqui MA; Perry CM
    BioDrugs; 2006; 20(5):313-6. PubMed ID: 17025377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.